Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 29, 2009updated 22 Nov 2021 9:35am

Abbott Strengthens Nutritional Business in India

Healthcare company Abbott has announced an agreement to acquire the nutrition businesses of India's Wockhardt Limited in a move that will substantially increase Abbot's presence on the subcontinent. Under the agreement Abbot will acquire the nutrition businesses of Wockhardt Limited, Car

By cms admin

Healthcare company Abbott has announced an agreement to acquire the nutrition businesses of India’s Wockhardt Limited in a move that will substantially increase Abbot’s presence on the subcontinent.

Under the agreement Abbot will acquire the nutrition businesses of Wockhardt Limited, Carol Info Services Limited, and certain Wockhardt subsidiaries in a cash deal worth approximately US$130m.

Wockhardt, based in Mumbai, India, has a significant presence in India’s paediatric and adult nutrition segments with infant formulas, weaning foods and adult protein supplements, including the sector’s leading adult protein supplement Protinex.

Abbott executive vice-president of global nutrition Holger Liepmann said that the acquisition would accelerate the company’s growth in India, where the nutritional market is expected to experience strong growth in the coming years.

“Combining these trusted nutrition products, local manufacturing capability and commercial infrastructure with Abbott’s existing paediatric and adult nutrition offerings positions Abbott very well to serve Indian consumers,” Liepmann said.

The acquisition includes approximately 600 employees in total. Abbott has approximately 1,500 employees in India across all of its businesses and has been operating in India since 1910.

Content from our partners
Extractables and leachables analysis in pharmaceutical quality control
How Hengst helped to keep Germany’s charity “star singers” shining
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

These transactions are subject to customary closing conditions and various approvals. Abbott expects the transactions to close in the second half of 2009.

Abbott already offers Isomil, PediaSure, Ensure and Glucerna in India and plans to introduce additional products from its nutritional portfolio in coming years.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU